Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Poor benefit/risk balance of intravenous immunoglobulins in DRESS.
Joly P, Janela B, Tetart F, Rogez S, Picard D, D'Incan M, Descamps V, Collet E, Roujeau JC, Musette P. Joly P, et al. Among authors: tetart f. Arch Dermatol. 2012 Apr;148(4):543-4. doi: 10.1001/archderm.148.4.dlt120002-c. Arch Dermatol. 2012. PMID: 22508885 Clinical Trial. No abstract available.
Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins).
Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, Lebrun-Vignes B, Gueudry J, Bequignon E, Zaghbib K, Royer G, Colin A, Do-Pham G, Bodemer C, Ortonne N, Barbaud A, Fardet L, Chosidow O, Wolkenstein P; French National Reference Center for Toxic Bullous Dermatoses. Ingen-Housz-Oro S, et al. Orphanet J Rare Dis. 2018 Apr 10;13(1):56. doi: 10.1186/s13023-018-0793-7. Orphanet J Rare Dis. 2018. PMID: 29636107 Free PMC article.
Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.
Plaquevent M, Tétart F, Fardet L, Ingen-Housz-Oro S, Valeyrie-Allanore L, Bernard P, Hebert V, Roussel A, Avenel-Audran M, Chaby G, D'Incan M, Ferrier-Le-Bouedec MC, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Collet E, Labeille B, Morice C, Richard MA, Bourgault-Villada I, Litrowski N, Bara C, Mahe E, Prost-Squarcioni C, Alexandre M, Quereux G, Bernier C, Soria A, Thomas-Beaulieu D, Pauwels C, Dereure O, Benichou J, Joly P; French Investigators for Skin Adverse Reaction to Drugs; French Study Group on Autoimmune Bullous Skin Diseases. Plaquevent M, et al. Among authors: tetart f. J Invest Dermatol. 2019 Apr;139(4):835-841. doi: 10.1016/j.jid.2018.10.045. Epub 2018 Dec 10. J Invest Dermatol. 2019. PMID: 30543900 Free article.
Tacrolimus ointment in the management of atopic keratoconjunctivitis.
Benaim D, Tétart F, Bauvin O, Delcampe A, Joly P, Muraine M, Gueudry J. Benaim D, et al. Among authors: tetart f. J Fr Ophtalmol. 2019 Apr;42(4):e147-e151. doi: 10.1016/j.jfo.2019.02.003. Epub 2019 Mar 7. J Fr Ophtalmol. 2019. PMID: 30851973
[Tacrolimus ointment in the management of atopic keratoconjunctivitis].
Benaim D, Tétart F, Bauvin O, Delcampe A, Joly P, Muraine M, Gueudry J. Benaim D, et al. Among authors: tetart f. J Fr Ophtalmol. 2019 May;42(5):435-440. doi: 10.1016/j.jfo.2018.07.018. Epub 2019 Mar 29. J Fr Ophtalmol. 2019. PMID: 30935698 French.
Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study.
Joly P, Tejedor I, Tetart F, Cailleux HC, Barrel A, De Preville PA, Mion-Mouton N, Gabison G, Baricault S, Tordeur CG, Dore MX, Rossi B, Bourseau-Quetier C, Chamaillard M, Ly S, Chosidow O, Richard-Lallemand MA, Rzeznik JC, Amici JM, Lair G, Bechu S, Benichou J, Thill C, Beylot-Barry M. Joly P, et al. Among authors: tetart f. J Am Acad Dermatol. 2021 May;84(5):1278-1284. doi: 10.1016/j.jaad.2020.09.055. Epub 2020 Sep 30. J Am Acad Dermatol. 2021. PMID: 33010323 Clinical Trial.
87 results